Literature DB >> 11880497

Inhibition of intracellular cholesterol transport alters presenilin localization and amyloid precursor protein processing in neuronal cells.

Heiko Runz1, Jens Rietdorf, Inge Tomic, Marina de Bernard, Konrad Beyreuther, Rainer Pepperkok, Tobias Hartmann.   

Abstract

Generation of amyloid-beta (Abeta) from the amyloid precursor protein (APP) requires proteolytic cleavage by two proteases, beta- and gamma-secretase. Several lines of evidence suggest a role for cholesterol on secretase activities, although the responsible cellular mechanisms remain unclear. Here we show that alterations in cholesterol transport from late endocytic organelles to the endoplasmic reticulum have important consequences for both APP processing and the localization of gamma-secretase-associated presenilins (PS). Exposure of neuronal cells to cholesterol transport-inhibiting agents resulted in a marked decrease in beta-cleavage of full-length APP. In contrast, gamma-secretase activity on APP C-terminal fragments was enhanced, increasing the production of both Abeta40 and Abeta42. Remarkably, retention of cholesterol in endosomal/lysosomal compartments induced PS1 and PS2 to accumulate in Rab7-positive vesicular organelles implicated in cholesterol sorting. Accumulation of PS in vesicular compartments was prominent in both Chinese hamster ovary cells deficient in Niemann-Pick C1 protein as well as in neuronal cells exposed to the cholesterol transport-inhibiting agent U18666A. Because Abeta42 also localized to PS1-containing vesicular compartments, organelles involved in cholesterol transport might represent an important site for gamma-secretase activity. Our results suggest that the subcellular distribution of cholesterol may be an important factor in how cholesterol alters Abeta production and the risk of Alzheimer's disease.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11880497      PMCID: PMC6758870     

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  49 in total

1.  Compartmentalization of beta-secretase (Asp2) into low-buoyant density, noncaveolar lipid rafts.

Authors:  D R Riddell; G Christie; I Hussain; C Dingwall
Journal:  Curr Biol       Date:  2001-08-21       Impact factor: 10.834

2.  Visualization of ER-to-Golgi transport in living cells reveals a sequential mode of action for COPII and COPI.

Authors:  S J Scales; R Pepperkok; T E Kreis
Journal:  Cell       Date:  1997-09-19       Impact factor: 41.582

3.  Hypercholesterolemia accelerates the Alzheimer's amyloid pathology in a transgenic mouse model.

Authors:  L M Refolo; B Malester; J LaFrancois; T Bryant-Thomas; R Wang; G S Tint; K Sambamurti; K Duff; M A Pappolla
Journal:  Neurobiol Dis       Date:  2000-08       Impact factor: 5.996

4.  Quantification of Alzheimer amyloid beta peptides ending at residues 40 and 42 by novel ELISA systems.

Authors:  M Jensen; T Hartmann; B Engvall; R Wang; S N Uljon; K Sennvik; J Näslund; F Muehlhauser; C Nordstedt; K Beyreuther; L Lannfelt
Journal:  Mol Med       Date:  2000-04       Impact factor: 6.354

5.  Statins and the risk of dementia.

Authors:  H Jick; G L Zornberg; S S Jick; S Seshadri; D A Drachman
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

6.  Alzheimer's disease-associated presenilin 1 in neuronal cells: evidence for localization to the endoplasmic reticulum-Golgi intermediate compartment.

Authors:  J G Culvenor; F Maher; G Evin; F Malchiodi-Albedi; R Cappai; J R Underwood; J B Davis; E H Karran; G W Roberts; K Beyreuther; C L Masters
Journal:  J Neurosci Res       Date:  1997-09-15       Impact factor: 4.164

Review 7.  Proteolytic processing and cell biological functions of the amyloid precursor protein.

Authors:  B De Strooper; W Annaert
Journal:  J Cell Sci       Date:  2000-06       Impact factor: 5.285

8.  Detection of a novel intraneuronal pool of insoluble amyloid beta protein that accumulates with time in culture.

Authors:  D M Skovronsky; R W Doms; V M Lee
Journal:  J Cell Biol       Date:  1998-05-18       Impact factor: 10.539

9.  The intracellular transport of low density lipoprotein-derived cholesterol is defective in Niemann-Pick type C fibroblasts.

Authors:  L Liscum; R M Ruggiero; J R Faust
Journal:  J Cell Biol       Date:  1989-05       Impact factor: 10.539

10.  Presenilin 1 controls gamma-secretase processing of amyloid precursor protein in pre-golgi compartments of hippocampal neurons.

Authors:  W G Annaert; L Levesque; K Craessaerts; I Dierinck; G Snellings; D Westaway; P S George-Hyslop; B Cordell; P Fraser; B De Strooper
Journal:  J Cell Biol       Date:  1999-10-18       Impact factor: 10.539

View more
  77 in total

1.  Involvement of oxidative stress-induced abnormalities in ceramide and cholesterol metabolism in brain aging and Alzheimer's disease.

Authors:  Roy G Cutler; Jeremiah Kelly; Kristin Storie; Ward A Pedersen; Anita Tammara; Kimmo Hatanpaa; Juan C Troncoso; Mark P Mattson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-02-15       Impact factor: 11.205

2.  β-sitosterol inhibits high cholesterol-induced platelet β-amyloid release.

Authors:  Chun Shi; Jun Liu; Fengming Wu; Xiaoming Zhu; David T Yew; Jie Xu
Journal:  J Bioenerg Biomembr       Date:  2011-10-04       Impact factor: 2.945

3.  Altered levels and distribution of amyloid precursor protein and its processing enzymes in Niemann-Pick type C1-deficient mouse brains.

Authors:  A Kodam; M Maulik; K Peake; A Amritraj; K S Vetrivel; G Thinakaran; J E Vance; S Kar
Journal:  Glia       Date:  2010-08-15       Impact factor: 7.452

4.  Effects of synaptic modulation on beta-amyloid, synaptophysin, and memory performance in Alzheimer's disease transgenic mice.

Authors:  Davide Tampellini; Estibaliz Capetillo-Zarate; Magali Dumont; Zhenyong Huang; Fangmin Yu; Michael T Lin; Gunnar K Gouras
Journal:  J Neurosci       Date:  2010-10-27       Impact factor: 6.167

5.  Statin treatment and a disease-specific pattern of beta-amyloid peptides in Alzheimer's disease.

Authors:  Kina Höglund; Steinar Syversen; Piotr Lewczuk; Anders Wallin; Jens Wiltfang; Kaj Blennow
Journal:  Exp Brain Res       Date:  2005-06-04       Impact factor: 1.972

Review 6.  Lipoprotein receptors and cholesterol in APP trafficking and proteolytic processing, implications for Alzheimer's disease.

Authors:  Maria-Paz Marzolo; Guojun Bu
Journal:  Semin Cell Dev Biol       Date:  2008-10-17       Impact factor: 7.727

Review 7.  Cellular membrane fluidity in amyloid precursor protein processing.

Authors:  Xiaoguang Yang; Grace Y Sun; Gunter P Eckert; James C-M Lee
Journal:  Mol Neurobiol       Date:  2014-02-20       Impact factor: 5.590

Review 8.  Use of in vivo models to study the role of cholesterol in the etiology of Alzheimer's disease.

Authors:  Mark Burns; Karen Duff
Journal:  Neurochem Res       Date:  2003-07       Impact factor: 3.996

9.  Association of gamma-secretase with lipid rafts in post-Golgi and endosome membranes.

Authors:  Kulandaivelu S Vetrivel; Haipeng Cheng; William Lin; Takashi Sakurai; Tong Li; Nobuyuki Nukina; Philip C Wong; Huaxi Xu; Gopal Thinakaran
Journal:  J Biol Chem       Date:  2004-08-17       Impact factor: 5.157

Review 10.  Cholesterol synthesis inhibitor U18666A and the role of sterol metabolism and trafficking in numerous pathophysiological processes.

Authors:  Richard J Cenedella
Journal:  Lipids       Date:  2009-05-14       Impact factor: 1.880

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.